Health · IPO · Medical · Stocks

Clean Science and Technology IPO : Subscribe or NOT?

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that

Clean Science and technology IPO– Incorporated in the year 2003, fine and specialty chemical manufacturing company, with innovative chemical processes developed in-house. Clean Science and Technology is a family-owned business and work primarily on developing clean and eco-friendly manufacturing processes.

Business — Clean Science Technology manufactures functionally critical specialty chemicals such as performance chemicals, pharmaceutical intermediates and FMCG chemicals. Its products are used as key starting level materials, as inhibitors, or as additives, by customers, for products

Region of operation — Customers include manufacturers and distributors in India as well as other international markets including China,
Europe, the US, Taiwan, Korea, and Japan. Approx. 66% of the company’s revenues come from exports

Offer purpose —  The IPO is 100% Offer For Sale (OFS) . None of the proceeds will flow to the company

Risks

Company will not get anything from IPO for future expansion etc

Highly competitive industry and well established peers

High dependence on exports

Strength

Globally leading supplier of certain chemicals; Ansole, 4-MAP, MEHQ, BHA, DCC, etc.

Strategically located manufacturing facility with close proximity to JNPT port to export products.

Strong long-term relationship with key customers.

Consistent track record of financial performance.

International presence with export to several countries i.e. China, USA, Korea, Japan, Taiwan, etc.

Future

Company has been growing well and automated operations, continued focus on product identification, process innovation, catalyst development, significant scale of operations as well as our measures towards strategic backward integration have all contributed to its success as one of the fastest growing and among the most profitable specialty chemical companies globally .

Valuations

Valuations are little on higher side and compare well with peers

Should we apply?

People can subscribe for long term and keep on adding on dips & review holdings with each quarter earnings

Also Read

Burger King IPO crisp Summary — Listing with huge gains as shared

CAMS IPO crisp summary — Listed with 20% gains as shared

Happiest Minds IPO crisp summary –Listed with substantial gains as shared

In case you have any questions/ queries, please feel free to reach me through Contact Form

Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.

Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.

Health · IPO · Medical · Stocks

KIMS IPO : Subscribe or NOT?

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that

KIMS IPO– Incorporated in the year 1973, KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered.

Business — The Hyderabad-based hospital chain offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities, and an additional quaternary healthcare facility in tier-1 cities. 

Region of operation –Main presence in 2 states , Telagana and Andhra Pradesh

Offer purpose —  The IPO includes a fresh issue of Rs 200 cr and an Offer For Sale (OFS) of up to 2.35 cr equity shares by the promoters and existing shareholders. This includes roughly 1.6 cr shares by the biggest investor in the company – General Atlantic Singapore KH Pte. for prepayment of borrowings and general purposes

Risks

Extremely high level of dependency on top 10 doctors

Concentrated region of operation

ARPOB is on the lower side as compared to industry numbers

Strength

Multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities at afforable rates

Better cost operating profile wrt peers due to operational leverage

Strong Balance sheet and operating margins

KIMS has expanded its business by successfully completing 4 significant acquisitions from FY 2017-2018 to FY 2019-2020 

Future

Company has plans to expand number of beds and expanding in Chennai and Bengaluru in coming years that will help the growth

As hospital chain becomes more mature, EBITDA margin will improve further

Valuations

Valuations are reasonable and compare well with peers

Source Business Line

Should we apply?

People can subscribe for long term and keep on adding on dips & review holdings with each quarter earnings

Also Read

Burger King IPO crisp Summary — Listing with huge gains as shared

CAMS IPO crisp summary — Listed with 20% gains as shared

Happiest Minds IPO crisp summary –Listed with substantial gains as shared

In case you have any questions/ queries, please feel free to reach me through Contact Form

Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.

Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.